Ruthirakuhan M

References (5)

Title : Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trial - Feldman_2026_Int.Psychogeriatr__100183
Author(s) : Feldman OJ , Herrmann N , Ruthirakuhan M , Gallagher D , NP LGV , Kiss A , Black SE , Lanctot KL
Ref : Int Psychogeriatr , :100183 , 2026
Abstract :
PubMedSearch : Feldman_2026_Int.Psychogeriatr__100183
PubMedID: 41530008

Title : Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase-derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance - Ryoo_2025_Alzheimers.Dement_21_e70718
Author(s) : Ryoo SW , Lin WZ , Magliocco A , Ruthirakuhan M , Wong YY , Perfetto SE , Huang C , Anita NZ , Arnott SR , Lang AE , Symons S , Hegele RA , Goubran M , Ramirez J , Ottoy J , Rabin JS , MacIntosh BJ , Lanctot KL , Liang N , Cogo-Moreira H , Taha AY , Swardfager W
Ref : Alzheimers Dement , 21 :e70718 , 2025
Abstract :
PubMedSearch : Ryoo_2025_Alzheimers.Dement_21_e70718
PubMedID: 41059602

Title : A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease - Herrmann_2016_J.Am.Med.Dir.Assoc_17_142
Author(s) : Herrmann N , O'Regan J , Ruthirakuhan M , Kiss A , Eryavec G , Williams E , Lanctot KL
Ref : J Am Med Dir Assoc , 17 :142 , 2016
Abstract :
PubMedSearch : Herrmann_2016_J.Am.Med.Dir.Assoc_17_142
PubMedID: 26482056

Title : Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease - Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417
Author(s) : Ruthirakuhan M , Herrmann N , Suridjan I , Abraham EH , Farber I , Lanctot KL
Ref : Expert Opin Pharmacother , 17 :2417 , 2016
Abstract :
PubMedSearch : Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417
PubMedID: 27825018

Title : Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments - Liu_2016_Curr.Alzheimer.Res_13_1134
Author(s) : Liu CS , Ruthirakuhan M , Chau SA , Herrmann N , Carvalho AF , Lanctot KL
Ref : Curr Alzheimer Res , 13 :1134 , 2016
Abstract :
PubMedSearch : Liu_2016_Curr.Alzheimer.Res_13_1134
PubMedID: 27137221